Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 19, 2026, 4:00 PM EST
Nexien BioPharma Market Cap
Nexien BioPharma has a market cap or net worth of $7.08 thousand as of January 21, 2026. Its market cap has decreased by -99.61% in one year.
Market Cap
7.08K
Enterprise Value
374.17K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2017, Nexien BioPharma's market cap has decreased from 10.47M to 7.08K, a decrease of -99.93%. That is a compound annual growth rate of -58.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 7.08K | - |
| Dec 12, 2025 | 7.08K | -98.21% |
| Dec 27, 2024 | 396.32K | -76.52% |
| Dec 29, 2023 | 1.69M | -53.72% |
| Dec 29, 2022 | 3.65M | -14.35% |
| Dec 31, 2021 | 4.26M | -14.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 723.02M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |